Nicotine Patch Trial in Syrian Primary Care Settings

• Status: Completed
• Trial end date: 2009-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The study is a two-arm, parallel group, randomized, placebo-controlled, double blind trial, conducted at four primary health care centers in Aleppo, Syria, to test the efficacy of transdermal nicotine patch therapy vs. placebo patch therapy, when delivered with behavioral counseling, on smoking cessation rates.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Memphis
• Treatments: Nicotine

Criteria

Inclusion Criteria:

• 18-65 years of age

• smoking continuously for at least one year and smoking 5 cigarettes every day

• Reside in the catchment area of one of the four primary care centers

Exclusion Criteria:

• diagnosed with a generalized dermatology disease, liver failure, hyperthyroidism, or pheochromocytoma

• current use of psychotropic drugs

• past year history of drug or alcohol abuse, unstable cardiovascular, psychiatric, or debilitating diseases based on physician assessment.

• currently pregnant, lactating, or intending to become pregnant in next 3 months